{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:59:51Z","timestamp":1793177991959,"version":"4.5.0"},"reference-count":94,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Red blood cell alloimmunization is typically associated with the transplacental transfer of incompatible fetal red blood cells into maternal circulation. Subsequent pregnancies can be affected by fetal anemia, hydrops fetalis, and perinatal death. Most cases of Rhesus D (RhD) alloimmunization due to pregnancy can be prevented by the proper administration of Rhesus immune globulin. However, an emerging practice of using low-titer, O, RhD-positive whole blood (LTOWB) in cases of life-threatening hemorrhage has the potential to increase the exposure of the female population to a new source of incompatible red blood cells.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To establish recommendations for the management of the red blood cell alloimmunized pregnancy.<\/jats:p>\n <\/jats:sec>\n \n Evidence<\/jats:title>\n Four working groups were assembled that included experts in (1) trauma and transfusion medicine, (2) hematology, (3) maternal-fetal medicine\/obstetrics, and (4) neonatology. Patient stakeholders and ethics representatives were included in each working group. The patient\/problem, intervention, comparison, outcome (PICO) framework was used to identify key clinical knowledge gaps. Library scientists at Johns Hopkins University performed systematic reviews and meta-analyses on these topics and provided final reports to the working groups. All 4 working groups participated in a Delphi process to refine recommendations and practice points for each PICO question that reflected consideration of the following factors: balance of benefits and harms; certainty of evidence; values and preferences; resource use and costs; ethics; equity; and feasibility.<\/jats:p>\n <\/jats:sec>\n \n Findings<\/jats:title>\n Seven clinical recommendations and 32 practice points were developed by the maternal-fetal medicine\/obstetrics working group. Recommendations included the following: use of cell-free fetal DNA to identify the at-risk fetus early in pregnancy, followed by immunomodulation with intravenous immune globulin (IVIG) in select cases; the implementation of middle cerebral artery peak systolic velocity Doppler measurements to detect fetal anemia earlier in pregnancy; the use of IVIG in patients with a documented antigen-positive fetus with a history of either fetal anemia or a fetal loss due to hemolytic disease of the fetus and newborn before 24 weeks\u2019 gestational age in a previous pregnancy; the continuation of intrauterine transfusion therapy until the end of the 35th week of pregnancy; and prolonging gestational age to between 37 weeks 0 days and 38 weeks 6 days before proceeding to delivery.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n These recommendations provide an updated approach to the management of red blood cell alloimmunized pregnancies. The lack of high-quality evidence limits the strength of the recommendations but points to the need for a standardized approach to this rare disease.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.44649","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:30:59Z","timestamp":1764001859000},"page":"e2544649","source":"Crossref","is-referenced-by-count":15,"title":["A Clinical Practice Guideline for the Management of Pregnancy Alloimmunized to Red Blood Cell Antigens"],"prefix":"10.1001","volume":"8","author":[{"suffix":"Jr","given":"Kenneth J.","family":"Moise","sequence":"first","affiliation":[{"name":"Dell Medical School\u2013University of Texas at Austin and the Comprehensive Fetal Care Center, Dell Children\u2019s Hospital, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara B.","family":"Markham","sequence":"additional","affiliation":[{"name":"University of Cincinnati Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Spinella","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly R.","family":"Sherwood","sequence":"additional","affiliation":[{"name":"Allo Hope Foundation, Tuscaloosa, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Malone","sequence":"additional","affiliation":[{"name":"Washington School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Espinoza","sequence":"additional","affiliation":[{"name":"McGovern Medical School, University of Texas Health Science Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Dizon-Townson","sequence":"additional","affiliation":[{"name":"Intermountain Health, University of Utah Health Sciences, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercer","sequence":"additional","affiliation":[{"name":"University of Arizona College of Medicine, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Miller","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pereira","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Sciscione","sequence":"additional","affiliation":[{"name":"Christiana Care Health Systems Newark, Newark, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza A.","family":"Shamshirsaz","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Fetal Care and Surgery Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Shanahan","sequence":"additional","affiliation":[{"name":"Allo Hope Foundation, Tuscaloosa, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Snowise","sequence":"additional","affiliation":[{"name":"Midwest Fetal Care Center, Children\u2019s Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Trevett","sequence":"additional","affiliation":[{"name":"Georgia Perinatal Consultants, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Gonz\u00e1lez V\u00e9lez","sequence":"additional","affiliation":[{"name":"University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Weathersby","sequence":"additional","affiliation":[{"name":"Allo Hope Foundation, Tuscaloosa, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"4","key":"zsc250008r1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000005709","article-title":"Management of red cell alloimmunization in pregnancy.","volume":"144","author":"Moise","year":"2024","journal-title":"Obstet Gynecol"},{"key":"zsc250008r2","doi-asserted-by":"publisher","author":"Crowder","journal-title":"Cochrane Database Syst Rev","DOI":"10.1002\/14651858.CD000020.pub2"},{"key":"zsc250008r3","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1111\/trf.15767","article-title":"Improved survival in critically injured combat casualties treated with fresh whole blood by forward surgical teams in Afghanistan.","volume":"60","author":"Gurney","year":"2020","journal-title":"Transfusion"},{"key":"zsc250008r4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/milmed\/usaa283","article-title":"Operationalizing the deployment of low-titer O-positive whole blood within a regional trauma system.","volume":"186","author":"Schaefer","year":"2021","journal-title":"Mil Med"},{"issue":"12","key":"zsc250008r5","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/j.1537-2995.2007.01446.x","article-title":"Detection of anti-D in D- recipients transfused with D+ red blood cells.","volume":"47","author":"Yazer","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"zsc250008r8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1471-0528.14050","article-title":"The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.","volume":"124","author":"Mackie","year":"2017","journal-title":"BJOG"},{"issue":"2","key":"zsc250008r9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11: making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zsc250008r10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/AOG.0000000000005692","article-title":"Cell-free DNA analysis for the determination of fetal red blood cell antigen genotype in individuals with alloimmunized pregnancies.","volume":"144","author":"Rego","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zsc250008r11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1056\/NEJMoa052855","article-title":"Doppler ultrasonography versus amniocentesis to predict fetal anemia.","volume":"355","author":"Oepkes","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"zsc250008r12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/00003081-200312000-00024","article-title":"Noninvasive diagnosis of fetal anemia.","volume":"46","author":"Detti","year":"2003","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"zsc250008r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.54330","article-title":"Variations and opportunities in postnatal management of hemolytic disease of the fetus and newborn.","volume":"8","author":"de Winter","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zsc250008r14","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1038\/s41598-023-39283-3","article-title":"Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fya antigens.","volume":"13","author":"Alford","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"zsc250008r15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12288-015-0616-0","article-title":"Fetal RHD genotyping from circulating cell-free fetal DNA in plasma of Rh negative pregnant women in Iran.","volume":"32","author":"Ahmadi","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"zsc250008r16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tracli.2020.10.011","article-title":"Prenatal RHD genotyping in Croatia: preliminary results.","volume":"28","author":"Bingulac-Popovic","year":"2021","journal-title":"Transfus Clin Biol"},{"issue":"6","key":"zsc250008r17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000490156","article-title":"Usefulness of non-invasive fetal RHD genotyping towards immunoprophylaxis optimization.","volume":"45","author":"Blanco","year":"2018","journal-title":"Transfus Med Hemother"},{"issue":"5","key":"zsc250008r18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/trf.16868","article-title":"Routine noninvasive prenatal screening for fetal Rh D in maternal plasma\u2014a 2-year experience from a single center in Belgium.","volume":"62","author":"Blomme","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"zsc250008r19","first-page":"66","article-title":"Genotyping approach for non-invasive foetal RHD detection in an admixed population.","volume":"15","author":"Boggione","year":"2017","journal-title":"Blood Transfus"},{"key":"zsc250008r20","doi-asserted-by":"publisher","first-page":"i5789","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.","volume":"355","author":"de Haas","year":"2016","journal-title":"BMJ"},{"issue":"11","key":"zsc250008r21","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/trf.17545","article-title":"Noninvasive screening of fetal RHD genotype in Chinese pregnant women with serologic RhD-negative phenotype.","volume":"63","author":"Duan","year":"2023","journal-title":"Transfusion"},{"issue":"7","key":"zsc250008r22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pathol.2017.08.010","article-title":"Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types.","volume":"49","author":"Hyland","year":"2017","journal-title":"Pathology"},{"issue":"6","key":"zsc250008r23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/tme.12605","article-title":"Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA.","volume":"29","author":"Londero","year":"2019","journal-title":"Transfus Med"},{"issue":"1","key":"zsc250008r24","first-page":"62","article-title":"Fetal RHD genotyping using real-time polymerase chain reaction analysis of cell-free fetal DNA in pregnancy of RhD negative women in south of Iran.","volume":"10","author":"Moezzi","year":"2016","journal-title":"Int J Fertil Steril"},{"issue":"3","key":"zsc250008r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265583","article-title":"RHD exon 5, 7 and 10 targeted non-invasive prenatal screening of fetal Rhesus-D (RhD) in selected RhD negative pregnant women in Ethiopia.","volume":"17","author":"Niguse","year":"2022","journal-title":"PLoS One"},{"key":"zsc250008r26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13104-016-2002-x","article-title":"Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.","volume":"9","author":"Papasavva","year":"2016","journal-title":"BMC Res Notes"},{"issue":"9","key":"zsc250008r27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/vox.13099","article-title":"Optimization of diagnostic strategy for non-invasive cell-free foetal RHD determination from maternal plasma.","volume":"116","author":"Pazourkova","year":"2021","journal-title":"Vox Sang"},{"issue":"1","key":"zsc250008r28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000370233","article-title":"Non-invasive prenatal RHD genotyping using cell-free fetal DNA from maternal plasma: an Italian experience.","volume":"42","author":"Picchiassi","year":"2015","journal-title":"Transfus Med Hemother"},{"issue":"1","key":"zsc250008r29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/ijmr.IJMR_1787_17","article-title":"Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA.","volume":"150","author":"Rather","year":"2019","journal-title":"Indian J Med Res"},{"issue":"11","key":"zsc250008r30","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1373\/clinchem.2015.239137","article-title":"Fetal sex and RHD Genotyping with digital PCR demonstrates greater sensitivity than real-time PCR.","volume":"61","author":"Sillence","year":"2015","journal-title":"Clin Chem"},{"issue":"12","key":"zsc250008r31","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1111\/1471-0528.13055","article-title":"Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS.","volume":"122","author":"Soothill","year":"2015","journal-title":"BJOG"},{"issue":"5","key":"zsc250008r32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/00365513.2018.1475681","article-title":"Determination of fetal RHD type in plasma of RhD negative pregnant women.","volume":"78","author":"S\u00f8rensen","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"issue":"11","key":"zsc250008r33","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/vox.13348","article-title":"Single-exon approach to non-invasive fetal RHD screening in early pregnancy: an update after 10?years\u2019 experience.","volume":"117","author":"Uzunel","year":"2022","journal-title":"Vox Sang"},{"key":"zsc250008r34","author":"Vivanti","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zsc250008r35","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s43032-020-00321-4","article-title":"Assessment of fetal Rhesus D and gender with cell-free DNA and exosomes from maternal blood.","volume":"28","author":"Yasa","year":"2021","journal-title":"Reprod Sci"},{"issue":"1","key":"zsc250008r36","first-page":"33","article-title":"Fetal RHD screening from circulating cell-free DNA in RhD-negative pregnant women.","volume":"26","author":"Zihan","year":"2023","journal-title":"Chinese Journal of Perinatal Medicine"},{"issue":"1","key":"zsc250008r37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tracli.2010.10.002","article-title":"[Fetal RHD genotyping by PCR using plasma from D negative pregnant women].","volume":"18","author":"Achargui","year":"2011","journal-title":"Transfus Clin Biol"},{"issue":"5","key":"zsc250008r38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000104803","article-title":"Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.","volume":"16","author":"Al-Yatama","year":"2007","journal-title":"Med Princ Pract"},{"issue":"2","key":"zsc250008r39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2478\/bjmg-2013-0029","article-title":"Determination of fetal Rhesus D status by maternal plasma DNA analysis.","volume":"16","author":"Aykut","year":"2013","journal-title":"Balkan J Med Genet"},{"issue":"8","key":"zsc250008r40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/pd.2770","article-title":"Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.","volume":"31","author":"Bombard","year":"2011","journal-title":"Prenat Diagn"},{"issue":"11","key":"zsc250008r41","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion"},{"issue":"4","key":"zsc250008r42","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00404-008-0774-5","article-title":"High throughput non-invasive determination of foetal Rhesus D status using automated extraction of cell-free foetal DNA in maternal plasma and mass spectrometry.","volume":"279","author":"Grill","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"zsc250008r43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5152\/jtgga.2010.04","article-title":"Detection of fetal RhD gene from maternal blood.","volume":"11","author":"G\u00fcnel","year":"2010","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"6","key":"zsc250008r44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1471-0528.2010.02518.x","article-title":"Diagnostic accuracy of noninvasive polymerase chain reaction testing for the determination of fetal rhesus C, c and E status in early pregnancy.","volume":"117","author":"Gutensohn","year":"2010","journal-title":"BJOG"},{"issue":"6","key":"zsc250008r45","first-page":"648","article-title":"Noninvasive fetal RhD genotyping using circulating cell-free fetal DNA from maternal plasma in RhD-negative pregnant women.","volume":"14","author":"Han","year":"2012","journal-title":"J Mol Diagn"},{"issue":"3","key":"zsc250008r46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1369\/jhc.4A6372.2005","article-title":"Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.","volume":"53","author":"Hromadnikova","year":"2005","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"zsc250008r47","first-page":"140","article-title":"Non-invasive determination of fetal c and E allele of RHCE gene via real-time PCR testing of extracellular DNA extracted from maternal plasma samples using QIAamp DSP virus kit.","volume":"8","author":"Hromadnikova","year":"2007","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"3","key":"zsc250008r48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/pd.1936","article-title":"Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.","volume":"28","author":"Li","year":"2008","journal-title":"Prenat Diagn"},{"issue":"24","key":"zsc250008r49","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","article-title":"Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.","volume":"339","author":"Lo","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"zsc250008r50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1590\/S0104-42302006000400022","article-title":"Fetal rhd genotyping from maternal plasma in a population with a highly diverse ethnic background.","volume":"52","author":"Machado","year":"2006","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"1","key":"zsc250008r51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000356078","article-title":"Noninvasive fetal RhD status determination in early pregnancy.","volume":"35","author":"Manzanares","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"2","key":"zsc250008r52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1537-2995.2007.01533.x","article-title":"Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.","volume":"48","author":"Minon","year":"2008","journal-title":"Transfusion"},{"issue":"4","key":"zsc250008r53","first-page":"246","article-title":"Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.","volume":"20","author":"Mohammed","year":"2010","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"zsc250008r54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/pd.4018","article-title":"Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers.","volume":"33","author":"Moise","year":"2013","journal-title":"Prenat Diagn"},{"key":"zsc250008r55","first-page":"36","article-title":"Clinical application of non-invasive fetal blood group genotyping in upper Austria.","volume":"40","author":"Polin","year":"2013","journal-title":"Transfus Med Hemother"},{"issue":"6","key":"zsc250008r56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.tracli.2008.01.003","article-title":"Noninvasive fetal RHD genotyping from maternal plasma: use of a new developed Free DNA Fetal Kit RhD.","volume":"14","author":"Rouillac-Le Sciellour","year":"2007","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"zsc250008r57","first-page":"34","article-title":"Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience.","volume":"10","author":"Sbarsi","year":"2012","journal-title":"Blood Transfus"},{"issue":"5","key":"zsc250008r58","first-page":"405","article-title":"Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma.","volume":"107","author":"Sesarini","year":"2009","journal-title":"Arch Argent Pediatr"},{"issue":"1","key":"zsc250008r59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1046\/j.0004-8666.2003.00011.x","article-title":"Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation.","volume":"43","author":"Siva","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"zsc250008r60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0301-2115(02)00356-1","article-title":"Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care.","volume":"108","author":"Turner","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"zsc250008r61","doi-asserted-by":"publisher","first-page":"251.e1","DOI":"10.1016\/j.ajog.2010.09.028","article-title":"Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing.","volume":"204","author":"Tynan","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"zsc250008r62","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2362.2009.02148.x","article-title":"Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma.","volume":"39","author":"Wang","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"5-6","key":"zsc250008r63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4414\/smw.2001.09660","article-title":"Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma.","volume":"131","author":"Zhong","year":"2001","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"zsc250008r64","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.ajog.2005.04.052","article-title":"Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.","volume":"193","author":"Zhou","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"zsc250008r65","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"6","key":"zsc250008r66","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1479-828X.2009.01091.x","article-title":"IVIG\u2014is it the answer? maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series.","volume":"49","author":"Connan","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"zsc250008r67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000111599","article-title":"Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.","volume":"23","author":"Fox","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"zsc250008r68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7196\/sajog.1629","article-title":"Maternal intravenous immunoglobulin: a non-invasive treatment option for Rhesus D-sensitised women with previous adverse pregnancy outcomes.","volume":"26","author":"Frank","year":"2020","journal-title":"S Afr J Obstet Gynaecol"},{"issue":"7","key":"zsc250008r69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102119","article-title":"Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: a case-control study.","volume":"50","author":"Maisonneuve","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"zsc250008r70","doi-asserted-by":"publisher","first-page":"138.e1","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.","volume":"196","author":"Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zsc250008r71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjh.18449","article-title":"Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.","volume":"200","author":"Vlachodimitropoulou","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"zsc250008r72","doi-asserted-by":"publisher","first-page":"291.e1","DOI":"10.1016\/j.ajog.2018.06.007","article-title":"Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn.","volume":"219","author":"Zwiers","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zsc250008r73","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ajog.2024.03.044","article-title":"Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis.","volume":"231","author":"Mustafa","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zsc250008r74","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/1471-0528.17674","article-title":"Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: a nationwide retrospective cohort study.","volume":"131","author":"Van\u2019t Oever","year":"2024","journal-title":"BJOG"},{"issue":"3","key":"zsc250008r75","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/0002-9378(89)90386-4","article-title":"Two hundred intrauterine exchange transfusions in severe blood incompatibilities.","volume":"161","author":"Poissonnier","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"zsc250008r76","author":"Slootweg","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zsc250008r77","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0002-9378(94)90477-4","article-title":"Erythropoietic suppression in fetal anemia because of Kell alloimmunization.","volume":"171","author":"Vaughan","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zsc250008r78","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/01.AOG.0000260957.77090.4e","article-title":"Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.","volume":"109","author":"van Wamelen","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zsc250008r79","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1471-0528.1991.tb13362.x","article-title":"Anti-Kell in pregnancy.","volume":"98","author":"Leggat","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"zsc250008r80","doi-asserted-by":"publisher","first-page":"e873","DOI":"10.1016\/S2352-3026(24)00239-4","article-title":"Management of pregnancies with anti-K alloantibodies and the predictive value of anti-K titration testing.","volume":"11","author":"Vlachodimitropoulou","year":"2024","journal-title":"Lancet Haematol"},{"issue":"1","key":"zsc250008r81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization.","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"zsc250008r82","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/1471-0528.12063","article-title":"Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.","volume":"120","author":"Lindenburg","year":"2013","journal-title":"BJOG"},{"key":"zsc250008r83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejogrb.2019.10.027","article-title":"Intraperitoneal transfusion for severe, early-onset rhesus disease requiring treatment before 20 weeks of gestation: a consecutive case series.","volume":"244","author":"Crawford","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"zsc250008r84","first-page":"746","article-title":"Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat.","volume":"109","author":"Zimmerman","year":"2002","journal-title":"BJOG"},{"issue":"2","key":"zsc250008r85","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"zsc250008r86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpeds.2021.02.066","article-title":"Neonatal morbidities in infants born late preterm at 35-36 weeks of gestation: a Swedish nationwide population-based study.","volume":"233","author":"Mitha","year":"2021","journal-title":"J Pediatr"},{"issue":"2","key":"zsc250008r87","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000343261","article-title":"Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.","volume":"103","author":"Smits-Wintjens","year":"2013","journal-title":"Neonatology"},{"key":"zsc250008r88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.11.003","article-title":"Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus.","author":"Mustafa","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zsc250008r90","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia\u2013diagnosis and management.","volume":"212","author":"Mari","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zsc250008r91","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/uog.29151","article-title":"Critical procedural steps in intrauterine transfusion: Delphi survey of international experts.","volume":"65","author":"Moise","year":"2025","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"zsc250008r92","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/AOG.0000000000005794","article-title":"Clinical validation of a prenatal cell-free DNA screening test for fetal RHD in a large US cohort.","volume":"145","author":"Gilstrop Thompson","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zsc250008r93","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ajog.2024.08.017","article-title":"The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient-the time has come.","volume":"232","author":"Moise","year":"2025","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zsc250008r94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tme.13098","article-title":"Guideline for the investigation and management of red cell antibodies in pregnancy: a British Society for Haematology guideline.","volume":"35","author":"Regan","year":"2025","journal-title":"Transfus Med"},{"key":"zsc250008r6","volume-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"zsc250008r7","unstructured":"Agree. The Agree II Instrument. Accessed February 3, 2025. https:\/\/www.agreetrust.org\/resource-centre\/agree-ii\/"},{"key":"zsc250008r89","unstructured":"Royal College of Obstetricians & Gynaecologists. The management of women with red cell antibodies during pregnancy. May 28, 2014. Accessed October 22, 2025. https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/the-management-of-women-with-red-cell-antibodies-during-pregnancy-green-top-guideline-no-65\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2841768\/moise_2025_sc_250008_1763396740.6649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:31:02Z","timestamp":1764001862000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2841768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":94,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.44649","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}